181 related articles for article (PubMed ID: 22466059)
1. Antipsychotic monotherapy and adjuvant psychotropic therapies in schizophrenia patients: effect on time to readmission.
Valevski A; Gilat Y; Olfson M; Benaroya-Milshtein N; Weizman A
Int Clin Psychopharmacol; 2012 May; 27(3):159-64. PubMed ID: 22466059
[TBL] [Abstract][Full Text] [Related]
2. Time to rehospitalization in patients with schizophrenia discharged on first generation antipsychotics, non-clozapine second generation antipsychotics, or clozapine.
Werneck AP; Hallak JC; Nakano E; Elkis H
Psychiatry Res; 2011 Aug; 188(3):315-9. PubMed ID: 21596442
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of clozapine use in delaying hospitalization in routine clinical practice: a 2 year observational study.
Nyakyoma K; Morriss R
Psychopharmacol Bull; 2010; 43(2):67-81. PubMed ID: 21052043
[TBL] [Abstract][Full Text] [Related]
4. [Intervals between hospitalisations in schizophrenia patients under antipsychotics in depot-form versus oral second generation antipsychotics].
Gutwinski S; Müller P; Koller M
Psychiatr Prax; 2007 Sep; 34(6):289-91. PubMed ID: 17806015
[TBL] [Abstract][Full Text] [Related]
5. Different serine and glycine metabolism in patients with schizophrenia receiving clozapine.
Hons J; Vasatova M; Cermakova E; Doubek P; Libiger J
J Psychiatr Res; 2012 Jun; 46(6):811-8. PubMed ID: 22502820
[TBL] [Abstract][Full Text] [Related]
6. First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients.
Popović I; Ravanić D; Popović V; Vladejić S; Stanojević A; Stojanović M
Psychiatr Danub; 2011 Dec; 23(4):384-8. PubMed ID: 22075740
[TBL] [Abstract][Full Text] [Related]
7. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing].
Mercier C; Bret P; Bret MC; Queuille E
Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368
[TBL] [Abstract][Full Text] [Related]
8. Ethnic comparisons of antipsychotic use in schizophrenia.
Wheeler A; Humberstone V; Robinson E
Aust N Z J Psychiatry; 2008 Oct; 42(10):863-73. PubMed ID: 18777230
[TBL] [Abstract][Full Text] [Related]
9. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
Wheeler AJ
Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
[TBL] [Abstract][Full Text] [Related]
10. Rehospitalization rates of patients recently discharged on a regimen of risperidone or clozapine.
Conley RR; Love RC; Kelly DL; Bartko JJ
Am J Psychiatry; 1999 Jun; 156(6):863-8. PubMed ID: 10360124
[TBL] [Abstract][Full Text] [Related]
11. Psychotropic medication changes, polypharmacy, and the risk of early readmission in suicidal adolescent inpatients.
Fontanella CA; Bridge JA; Campo JV
Ann Pharmacother; 2009 Dec; 43(12):1939-47. PubMed ID: 19934394
[TBL] [Abstract][Full Text] [Related]
12. Combined treatment with amisulpride in patients with schizophrenia discharged from a short-term hospitalization unit: a 1-year retrospective study.
Molina JD; Lerma-Carrillo I; Leonor M; Pascual F; Blasco-Fontecilla H; González-Parra S; López-Muñoz F; Alamo C
Clin Neuropharmacol; 2009; 32(1):10-5. PubMed ID: 18978498
[TBL] [Abstract][Full Text] [Related]
13. [Medico-economic evaluation of treatment with clozapine versus treatment with previous neuroleptics].
Geronimi-Ferret D; Lesay M; Barges-Bertocchio MH; Cornet-Bonnefont M; Robert H
Encephale; 1997 Sep; 23 Spec No 4():24-31. PubMed ID: 9417402
[TBL] [Abstract][Full Text] [Related]
14. A clinical case series of switching from antipsychotic polypharmacy to monotherapy with a second-generation agent on patients with chronic schizophrenia.
Suzuki T; Uchida H; Watanabe K; Yagi G; Kashima H
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):361-9. PubMed ID: 14751434
[TBL] [Abstract][Full Text] [Related]
15. A controlled, mirror-image study of second-generation antipsychotics in the treatment of schizophrenia.
Taylor D; Hayhurst K; Kerwin R
Int Clin Psychopharmacol; 2007 May; 22(3):133-6. PubMed ID: 17414738
[TBL] [Abstract][Full Text] [Related]
16. A study of polypharmacy with second generation antipsychotics in patients with severe and persistent mental illness.
Megna JL; Kunwar AR; Mahlotra K; Sauro MD; Devitt PJ; Rashid A
J Psychiatr Pract; 2007 Mar; 13(2):129-37. PubMed ID: 17414692
[TBL] [Abstract][Full Text] [Related]
17. Several prescription patterns of antipsychotic drugs influence cognitive functions in Japanese chronic schizophrenia patients.
Hori H; Yoshimura R; Katsuki A; Hayashi K; Ikenouchi-Sugita A; Umene-Nakano W; Nakamura J
Int J Psychiatry Clin Pract; 2012 Jun; 16(2):138-42. PubMed ID: 22136174
[TBL] [Abstract][Full Text] [Related]
18. Time to rehospitalization of clozapine versus risperidone in the naturalistic treatment of comorbid alcohol use disorder and schizophrenia.
Kim JH; Kim D; Marder SR
Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):984-8. PubMed ID: 18262321
[TBL] [Abstract][Full Text] [Related]
19. Diffusion of a new drug: a comparative analysis of adoption, treatment complexity, and persistence of risperidone long-acting injectable therapy in the Netherlands.
Pechlivanoglou P; Vehof J; van Agthoven M; de Jong-van den Berg LT; Postma MJ
Clin Ther; 2010 Jan; 32(1):108-18. PubMed ID: 20171417
[TBL] [Abstract][Full Text] [Related]
20. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
Bret P; Bret MC; Queuille E
Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]